Summary

The market for fatty acid supplements is expected to experience robust growth in the coming years, driven by increasing awareness about the health benefits associated with these essential nutrients. Fatty acids are vital components for maintaining overall health, contributing significantly to cardiovascular health, cognitive function, and other critical bodily processes. However, since the human body cannot produce many of these essential acids on its own, they must be obtained through diet or supplements.With the market valued at $5.77 billion in 2024, it is expected to reach $9.70 billion by 2031, reflecting a robust CAGR of 7.70%.

Fatty Acid Supplements Consumption Analysis

Over recent years, the global market for fatty acid supplements has seen considerable expansion, supported by growing consumer awareness and increased emphasis on health and wellness. Fatty acids are recognized for their essential role in human nutrition, with particular emphasis on their importance in maintaining cardiovascular health and supporting cognitive development. The increasing consumption of these supplements is reflective of a broader trend toward preventive healthcare and the proactive management of health through diet and nutrition.

Education and awareness campaigns have played a pivotal role in increasing the general population's understanding of the benefits of fatty acids. As more people become aware of the health advantages of these nutrients, there has been a noticeable shift towards incorporating fatty acid supplements into daily health regimens. This shift is further supported by ongoing research, which continues to uncover new potential health benefits of fatty acids, including their role in managing conditions like polycystic ovary syndrome (PCOS) and obesity.

Key Trends in the Fatty Acid Supplements Market

Increasing Popularity of Omega-3 Fatty Acids

Omega-3 fatty acids have gained significant attention for their role in supporting regular metabolic activities and regulating cholesterol levels. The growing popularity of omega-3s is closely linked to the increasing awareness of the benefits of a healthy lifestyle. Over the years, omega-3 fatty acids have been used in the treatment of various conditions, including heart disease, cognitive decline, and even certain skin and hair conditions. As research continues to validate the benefits of omega-3s, their application in the food industry, particularly in processed foods, has increased.

One of the notable trends in the fatty acid supplements market is the growing demand for omega-3s in infant formulas. This trend is particularly strong in regions with high birth rates, where the health benefits of omega-3s for infants are becoming increasingly recognized. The use of omega-3s in functional beverages is another emerging trend, offering significant growth opportunities for manufacturers looking to cater to health-conscious consumers.

Cultural Customization to Target Specific Populations

As consumer preferences evolve, food and beverage companies are increasingly turning to cultural customization as a strategy to enhance market penetration. This approach involves tailoring products to meet the specific needs and preferences of different ethnic groups and populations. In the case of fatty acid supplements, this might involve developing products that cater to specific dietary habits or cultural practices. The trend toward cultural customization is expected to continue, driven by the growing demand for personalized nutrition solutions.

Preference for Non-Modified Functional Ingredients

The global food and beverage market has seen a rising demand for non-GMO (genetically modified organism) food ingredients, particularly among health-conscious consumers. This trend extends to the fatty acid supplements market, where there is a growing preference for non-modified functional ingredients. This demand is particularly strong among parents, who are increasingly concerned about the ingredients used in products for their children. As a result, manufacturers are focusing on developing non-GMO certified products to meet this demand.

Growing Preference for Mono & Poly-Unsaturated Fatty Acids

The health benefits of polyunsaturated fatty acids (PUFAs) are well-documented, particularly in relation to heart health. PUFAs are known to lower LDL (low-density lipoprotein) cholesterol levels and reduce the risk of cardiovascular disease. As awareness of these benefits grows, there has been an increasing preference for mono- and poly-unsaturated fats over saturated fats. The American Heart Association (AHA) recommends incorporating PUFAs into the regular diet to lower the risk of heart disease and cognitive decline. Foods rich in PUFAs, such as tofu, flaxseed, and walnuts, are becoming more popular as consumers seek to improve their health through diet.

Rising Awareness of PUFAs as a Preventive Solution

Chronic diseases such as cardiovascular disease, stroke, cancer, and diabetes are on the rise globally, prompting increased interest in preventive health measures. PUFAs, particularly omega-3 and omega-6 fatty acids, are gaining recognition for their potential to reduce the risk of these conditions. Awareness of the health benefits of PUFAs is particularly high in regions like North America and Western Europe, where consumers are increasingly incorporating these fatty acids into their diets. Research has also highlighted the potential role of PUFAs in improving mental health, with studies suggesting that omega-3s can reduce symptoms of ADHD in children and enhance cognitive function.

Global Outlook for the Fatty Acid Supplements Market

Geographically, the fatty acid supplements market is characterized by significant regional variation. North America represents the largest market share, driven by a high level of health-consciousness among consumers. Europe is another major market, with growth attributed to increasing awareness of the benefits of omega-3 fatty acids. In contrast, the South Asia & Pacific and East Asia regions are emerging as fast-growing markets, particularly for omega-3 supplements, due to high birth rates and the increasing importance of infant nutrition.

In East Asia and South Asia & Pacific, the extensive aquaculture industry plays a critical role in the production of fatty acid supplements, particularly those derived from marine sources. The rapid urbanization in these regions has also contributed to a shift towards dietary supplementation, as consumers seek to ensure they are meeting their nutritional needs in the face of changing lifestyles.

Category-wise Insights

Dominance of Marine Oils

Marine oils, particularly those rich in omega-3 fatty acids, are expected to dominate the fatty acid supplements market in the coming years. The high omega-3 content in seafood has gained significant popularity among health-conscious consumers, who are increasingly incorporating these supplements into their diets. As awareness of the benefits of omega-3s continues to grow, the marine oils segment is likely to maintain its leading position in the market.

Growth in Dietary Supplement Applications

The dietary supplement segment is set to see substantial growth, driven by the increasing consumer focus on maintaining health and wellness through supplementation. The COVID-19 pandemic has heightened awareness of the importance of a strong immune system, leading many consumers to turn to supplements as a way to support their health. As a result, the dietary supplement segment is expected to hold a significant share of the fatty acid supplements market.

Competitive Analysis

The global fatty acid supplements market is characterized by the presence of both large multinational companies and regional players. Major international companies dominate the market, particularly in North America and Europe, where there is a high demand for health-focused products. These companies offer a wide range of fatty acid supplements, catering to diverse consumer needs.

Key companies profiled

• Arista Industries Inc.

• Omega Protein Corporation

• Axellus AS

• Copeinca AS

• Croda Health Care

• Koninklijke DSM N.V.

• Nutriteck

• Avestia Pharma

• Xena Bio Herbals

• Precision Nutrition

• Qualitas Health

• Valensa International

• Your Essential Supplements, Inc.

• Nordic Naturals

• ARKLE Veterinary Care, LLC

• Efamol Ltd

• Omega Prote

Fatty Acid Supplements Market by Category

By Source:

• Marine Oil

• Algal Oil

• Flaxseed Oil

• Others

By Application:

• Dietary Supplements

• Functional Food

• Beverages

• Infant Formula

• Pharmaceuticals

• Others

By Distribution Channel:

• Supermarket/Hypermarket

• Department Stores

• Drug Stores

• Online

By Region:

• North America

• Latin America

• Europe

• South Asia & Pacific

• East Asia

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Fatty Acid Supplements Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2023
3.1. Global Fatty Acid Supplements Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2023
4.1. Global Average Price Analysis, by Application/Source, US$ Per Ton, 2019-2023
4.2. Prominent Factor Affecting Fatty Acid Supplements Prices
4.3. Global Average Price Analysis, by Region, US$ Per MMT
5. Global Fatty Acid Supplements Market Outlook, 2019-2031
5.1. Global Fatty Acid Supplements Market Outlook, by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
5.1.1. Key Highlights
5.1.1.1. Marine Oil
5.1.1.2. Algal Oil
5.1.1.3. Flaxseed Oil
5.1.1.4. Others
5.2. Global Fatty Acid Supplements Market Outlook, by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
5.2.1. Key Highlights
5.2.1.1. Dietary Supplements
5.2.1.2. Functional Food
5.2.1.3. Beverages
5.2.1.4. Infant Formula
5.2.1.5. Pharmaceuticals
5.2.1.6. Others
5.3. Global Fatty Acid Supplements Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
5.3.1. Key Highlights
5.3.1.1. Supermarket/Hypermarket
5.3.1.2. Department Stores
5.3.1.3. Drug Stores
5.3.1.4. Online
5.4. Global Fatty Acid Supplements Market Outlook, by Region, Value (US$ Bn) and Volume (Ton), 2019-2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Fatty Acid Supplements Market Outlook, 2019-2031
6.1. North America Fatty Acid Supplements Market Outlook, by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
6.1.1. Key Highlights
6.1.1.1. Marine Oil
6.1.1.2. Algal Oil
6.1.1.3. Flaxseed Oil
6.1.1.4. Others
6.2. North America Fatty Acid Supplements Market Outlook, by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
6.2.1. Key Highlights
6.2.1.1. Dietary Supplements
6.2.1.2. Functional Food
6.2.1.3. Beverages
6.2.1.4. Infant Formula
6.2.1.5. Pharmaceuticals
6.2.1.6. Others
6.3. North America Fatty Acid Supplements Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
6.3.1. Key Highlights
6.3.1.1. Supermarket/Hypermarket
6.3.1.2. Department Stores
6.3.1.3. Drug Stores
6.3.1.4. Online
6.4. North America Fatty Acid Supplements Market Outlook, by Country, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.1. Key Highlights
6.4.1.1. U.S. Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.1.2. U.S. Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.1.3. U.S. Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.1.4. Canada Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.1.5. Canada Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.1.6. Canada Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Fatty Acid Supplements Market Outlook, 2019-2031
7.1. Europe Fatty Acid Supplements Market Outlook, by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.1.1. Key Highlights
7.1.1.1. Marine Oil
7.1.1.2. Algal Oil
7.1.1.3. Flaxseed Oil
7.1.1.4. Others
7.2. Europe Fatty Acid Supplements Market Outlook, by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.2.1. Key Highlights
7.2.1.1. Dietary Supplements
7.2.1.2. Functional Food
7.2.1.3. Beverages
7.2.1.4. Infant Formula
7.2.1.5. Pharmaceuticals
7.2.1.6. Others
7.3. Europe Fatty Acid Supplements Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.3.1. Key Highlights
7.3.1.1. Supermarket/Hypermarket
7.3.1.2. Department Stores
7.3.1.3. Drug Stores
7.3.1.4. Online
7.4. Europe Fatty Acid Supplements Market Outlook, by Country, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1. Key Highlights
7.4.1.1. Germany Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.2. Germany Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.3. Germany Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.4. U.K. Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.5. U.K. Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.6. U.K. Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.7. France Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.8. France Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.9. France Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.10. Italy Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.11. Italy Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.12. Italy Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.13. Turkey Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.14. Turkey Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.15. Turkey Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.16. Russia Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.17. Russia Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.18. Russia Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.19. Rest of Europe Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.20. Rest of Europe Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.1.21. Rest of Europe Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Fatty Acid Supplements Market Outlook, 2019-2031
8.1. Asia Pacific Fatty Acid Supplements Market Outlook, by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.1.1. Key Highlights
8.1.1.1. Marine Oil
8.1.1.2. Algal Oil
8.1.1.3. Flaxseed Oil
8.1.1.4. Others
8.2. Asia Pacific Fatty Acid Supplements Market Outlook, by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.2.1. Key Highlights
8.2.1.1. Dietary Supplements
8.2.1.2. Functional Food
8.2.1.3. Beverages
8.2.1.4. Infant Formula
8.2.1.5. Pharmaceuticals
8.2.1.6. Others
8.3. Asia Pacific Fatty Acid Supplements Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.3.1. Key Highlights
8.3.1.1. Supermarket/Hypermarket
8.3.1.2. Department Stores
8.3.1.3. Drug Stores
8.3.1.4. Online
8.4. Asia Pacific Fatty Acid Supplements Market Outlook, by Country, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1. Key Highlights
8.4.1.1. China Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.2. China Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.3. China Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.4. Japan Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.5. Japan Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.6. Japan Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.7. South Korea Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.8. South Korea Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.9. South Korea Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.10. India Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.11. India Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.12. India Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.13. Southeast Asia Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.14. Southeast Asia Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.15. Southeast Asia Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.16. Rest of Asia Pacific Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.17. Rest of Asia Pacific Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.1.18. Rest of Asia Pacific Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Fatty Acid Supplements Market Outlook, 2019-2031
9.1. Latin America Fatty Acid Supplements Market Outlook, by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
9.1.1. Key Highlights
9.1.1.1. Marine Oil
9.1.1.2. Algal Oil
9.1.1.3. Flaxseed Oil
9.1.1.4. Others
9.2. Latin America Fatty Acid Supplements Market Outlook, by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
9.2.1. Key Highlights
9.2.1.1. Dietary Supplements
9.2.1.2. Functional Food
9.2.1.3. Beverages
9.2.1.4. Infant Formula
9.2.1.5. Pharmaceuticals
9.2.1.6. Others
9.3. Latin America Fatty Acid Supplements Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
9.3.1. Key Highlights
9.3.1.1. Supermarket/Hypermarket
9.3.1.2. Department Stores
9.3.1.3. Drug Stores
9.3.1.4. Online
9.4. Latin America Fatty Acid Supplements Market Outlook, by Country, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1. Key Highlights
9.4.1.1. Brazil Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.2. Brazil Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.3. Brazil Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.4. Mexico Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.5. Mexico Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.6. Mexico Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.7. Argentina Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.8. Argentina Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.9. Argentina Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.10. Rest of Latin America Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.11. Rest of Latin America Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.1.12. Rest of Latin America Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Fatty Acid Supplements Market Outlook, 2019-2031
10.1. Middle East & Africa Fatty Acid Supplements Market Outlook, by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
10.1.1. Key Highlights
10.1.1.1. Marine Oil
10.1.1.2. Algal Oil
10.1.1.3. Flaxseed Oil
10.1.1.4. Others
10.2. Middle East & Africa Fatty Acid Supplements Market Outlook, by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
10.2.1. Key Highlights
10.2.1.1. Dietary Supplements
10.2.1.2. Functional Food
10.2.1.3. Beverages
10.2.1.4. Infant Formula
10.2.1.5. Pharmaceuticals
10.2.1.6. Others
10.3. Middle East & Africa Fatty Acid Supplements Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
10.3.1. Key Highlights
10.3.1.1. Supermarket/Hypermarket
10.3.1.2. Department Stores
10.3.1.3. Drug Stores
10.3.1.4. Online
10.4. Middle East & Africa Fatty Acid Supplements Market Outlook, by Country, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1. Key Highlights
10.4.1.1. GCC Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.2. GCC Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.3. GCC Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.4. South Africa Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.5. South Africa Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.6. South Africa Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.7. Egypt Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.8. Egypt Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.9. Egypt Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.10. Nigeria Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.11. Nigeria Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.12. Nigeria Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.13. Rest of Middle East & Africa Fatty Acid Supplements Market by Source, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.14. Rest of Middle East & Africa Fatty Acid Supplements Market by Application, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.1.15. Rest of Middle East & Africa Fatty Acid Supplements Market by Distribution Channel, Value (US$ Bn) and Volume (Ton), 2019-2031
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2022
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. EPAX AS
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Arista Industries Inc.
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Omega Protein Corporation
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Axellus AS
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Copeinca AS
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Croda Health Care
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Koninklijke DSM N.V.
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Nutriteck
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Avestia Pharma
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. Xena Bio Herbals
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Precision Nutrition
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Qualitas Health
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. Valensa International
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
11.4.14. Your Essential Supplements, Inc.
11.4.14.1. Company Overview
11.4.14.2. Product Portfolio
11.4.14.3. Financial Overview
11.4.14.4. Business Strategies and Development
11.4.15. Nordic Naturals
11.4.15.1. Company Overview
11.4.15.2. Product Portfolio
11.4.15.3. Financial Overview
11.4.15.4. Business Strategies and Development
11.4.16. ARKLE Veterinary Care, LLC
11.4.16.1. Company Overview
11.4.16.2. Product Portfolio
11.4.16.3. Financial Overview
11.4.16.4. Business Strategies and Development
11.4.17. Efamol Ltd
11.4.17.1. Company Overview
11.4.17.2. Product Portfolio
11.4.17.3. Financial Overview
11.4.17.4. Business Strategies and Development
11.4.18. Omega Prote
11.4.18.1. Company Overview
11.4.18.2. Product Portfolio
11.4.18.3. Financial Overview
11.4.18.4. Business Strategies and Development

12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations